Luo Mary Z.'s Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Jan 11, 2024
- Accession no.
- 0001104659-24-003330
- Filed
- Jan 11, 2024, 4:37 PM ET
- Trade date
- Jan 10, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $7.17M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Luo Mary Z.CIK 0001611156 | Director, Officer (COO,Chief Scientist & Chairman), 10% Owner |
| Zhang Jack Y.CIK 0001611157 | Director, Officer (CEO & Chief Scientific Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Common Stock | SSaleDisposed | −78,236 | $54.32 | −$4,249,967.29 | 1,157,566 | Direct | |
| Jan 10, 2024 | Common Stock | SSaleDisposed | −50,514 | $54.89 | −$2,772,506.35 | 1,107,052 | Direct | |
| Jan 10, 2024 | Common Stock | SSaleDisposed | −920 | $55.95 | −$51,477.13 | 1,106,132 | Direct | |
| Jan 10, 2024 | Common Stock | SSaleDisposed | −1,716 | $57.00 | −$97,816.98 | 1,104,416 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.